Singlera Genomics Inc

Fourth-quarter device financing reached $4.2bn, up from the previous quarter’s $3.3bn. The initial public offering category made up the most, accounting for $1.3bn, or 32%, of the Q4 total, followed b

Aiming to become a global superpower in the area, China is strongly pushing a homegrown precision medicine initiative and has officially declared that therapies derived from next-generation genomic se

[ Editors' note: For more details about VC deals in 2016 and previous years, go to Medtech Insight 's VC deal tracker: https://medtech.pharmamedtechbi.com/datasets/vc-funding .] Venture financi